SubHero Banner
Text

4th Quarter 2024

Key topics in this quarter’s edition include:

  • Ozempic for chronic kidney disease and type 2 diabetes
  • Zepbound for obstructive sleep apnea and obesity
  • Suzetrigine for acute pain

Download PDF

Text